• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

维拉帕米、普萘洛尔和硝酸异山梨酯与安慰剂治疗心绞痛的双盲评估。

Double-blind evaluation of verapamil, propranolol, and isosorbide dinitrate against a placebo in the treatment of angina pectoris.

作者信息

Livesley B, Catley P F, Campbell R C, Oram S

出版信息

Br Med J. 1973 Feb 17;1(5850):375-8. doi: 10.1136/bmj.1.5850.375.

DOI:10.1136/bmj.1.5850.375
PMID:4570671
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC1588308/
Abstract

In the treatment of angina pectoris a double-blind evaluation of verapamil (Cordilox) at two dose levels-namely, 80 mg thrice daily and 120 mg thrice daily-propranolol (Inderal) 100 mg thrice daily, and isosorbide dinitrate (Vascardin) 20 mg thrice daily has been made against a placebo. The assessment was based on relief from daily attacks of angina on effort and the response to a whole-body exercise test. We can find no statistically significant difference between the effects of verapamil (120 mg three times a day) and propranolol (100 mg three times a day) in the treatment of angina of effort. Both of these preparations are more effective than a placebo both in the reduction of daily attacks (P < 0.01) and in the prolongation of exercise test (P < 0.05). Isosorbide dinitrate (20 mg three times a day) appears to be no more effective than a placebo in the treatment of angina on effort, but 14 out of 32 patients experienced headache of such severity that even when the dose was reduced to 10 mg thrice daily this drug therapy had to be withdrawn. Both propranolol (100 mg three times a day) and verapamil (120 mg three times a day) had a significant lowering effect on the diastolic blood pressure as measured with the patient standing (P < 0.01).

摘要

在心绞痛治疗中,针对安慰剂,对两种剂量水平的维拉帕米(异搏定)——即每日三次,每次80毫克和每日三次,每次120毫克——普萘洛尔(心得安)每日三次,每次100毫克,以及硝酸异山梨酯(消心痛)每日三次,每次20毫克进行了双盲评估。评估基于努力时每日心绞痛发作的缓解情况以及对全身运动试验的反应。我们发现在劳力性心绞痛治疗中,维拉帕米(每日三次,每次120毫克)和普萘洛尔(每日三次,每次100毫克)的效果之间没有统计学上的显著差异。这两种制剂在减少每日发作次数(P < 0.01)和延长运动试验时间(P < 0.05)方面都比安慰剂更有效。硝酸异山梨酯(每日三次,每次20毫克)在劳力性心绞痛治疗中似乎并不比安慰剂更有效,但32名患者中有14名经历了严重的头痛,以至于即使将剂量减至每日三次,每次10毫克,这种药物治疗也不得不停用。普萘洛尔(每日三次,每次100毫克)和维拉帕米(每日三次,每次120毫克)在患者站立时测量的舒张压方面都有显著的降低作用(P < 0.01)。

相似文献

1
Double-blind evaluation of verapamil, propranolol, and isosorbide dinitrate against a placebo in the treatment of angina pectoris.维拉帕米、普萘洛尔和硝酸异山梨酯与安慰剂治疗心绞痛的双盲评估。
Br Med J. 1973 Feb 17;1(5850):375-8. doi: 10.1136/bmj.1.5850.375.
2
Therapy of angina pectoris with propranolol and long-acting nitrates.普萘洛尔与长效硝酸盐类药物治疗心绞痛
Circulation. 1969 Dec;40(6):847-53.
3
Therapy of angina pectoris with propranolol and long-acting nitrates.普萘洛尔与长效硝酸盐类药物治疗心绞痛
Circulation. 1969 Dec;40(6):847-53.
4
Evaluation of propranolol and of isosorbide dinitrate in angina pectoris.普萘洛尔和硝酸异山梨酯治疗心绞痛的评估。
Curr Ther Res Clin Exp. 1969 Feb;11(2):80-6.
5
Comparison of the antianginal effectiveness of nifedipine, verapamil, and isosorbide dinitrate in patients receiving propranolol: a double-blind study.硝苯地平、维拉帕米和硝酸异山梨酯在接受普萘洛尔治疗的患者中的抗心绞痛疗效比较:一项双盲研究。
Circulation. 1983 Sep;68(3):568-75. doi: 10.1161/01.cir.68.3.568.
6
Propranolol and isosorbide dinitrate synergism in angina pectoris.普萘洛尔与硝酸异山梨酯治疗心绞痛的协同作用。
Am J Cardiol. 1968 Jan;21(1):44-54. doi: 10.1016/0002-9149(68)90012-x.
7
[Methods o clinical evaluation of therapeutic agents for the treatment of angina pectoris].[治疗心绞痛治疗药物的临床评价方法]
Nihon Ika Daigaku Zasshi. 1970;37(5):343-58.
8
Comparison of the antianginal efficacy of isosorbide dinitrate (ISDN) 40 mg and verapamil 120 mg three times daily in the acute trial and following two-week treatment.在急性试验以及为期两周的治疗后,比较每日三次服用40毫克硝酸异山梨酯(ISDN)和120毫克维拉帕米的抗心绞痛疗效。
Eur Heart J. 1988 Feb;9(2):149-58. doi: 10.1093/oxfordjournals.eurheartj.a062468.
9
Propranolol combined with isosorbide dinitrate versus placebo in angina pectoris.普萘洛尔联合硝酸异山梨酯与安慰剂治疗心绞痛的对比研究
N Engl J Med. 1969 Apr 17;280(16):847-50. doi: 10.1056/NEJM196904172801601.
10
[The effects of verapamil on angina threshold during exercise (author's transl)].维拉帕米对运动时心绞痛阈值的影响(作者译)
G Ital Cardiol. 1976;6(7):1238-45.

引用本文的文献

1
Verapamil and Alzheimer's Disease: Past, Present, and Future.维拉帕米与阿尔茨海默病:过去、现在与未来
Front Pharmacol. 2020 May 5;11:562. doi: 10.3389/fphar.2020.00562. eCollection 2020.
2
Discovery and Development of Calcium Channel Blockers.钙通道阻滞剂的发现与研发
Front Pharmacol. 2017 May 29;8:286. doi: 10.3389/fphar.2017.00286. eCollection 2017.
3
Calcium antagonists: A new class of therapeutic agents.钙拮抗剂:一类新型治疗药物。
Cardiovasc Dis. 1981 Sep;8(3):413-420.
4
Differential effects of the calcium antagonist, verapamil, on lumen sizes of terminal arterioles and muscular venules in the rat mesenteric, pial and skeletal muscle microvasculatures.钙拮抗剂维拉帕米对大鼠肠系膜、软脑膜和骨骼肌微血管系统中终末小动脉和肌性微静脉管腔大小的不同影响。
Br J Pharmacol. 1980 Nov;70(3):351-3. doi: 10.1111/j.1476-5381.1980.tb08709.x.
5
Role of calcium antagonists in cardiovascular therapy.钙拮抗剂在心血管治疗中的作用。
Br Heart J. 1981 Jul;46(1):8-16. doi: 10.1136/hrt.46.1.8.
6
Additive antianginal effect of verapamil in patients receiving propranolol.维拉帕米对接受普萘洛尔治疗患者的附加抗心绞痛作用。
Br Med J (Clin Res Ed). 1982 Apr 10;284(6322):1067-70. doi: 10.1136/bmj.284.6322.1067.
7
Objective assessment of antianginal treatment: a double-blind comparison of propranolol, nifedipine, and their combination.抗心绞痛治疗的客观评估:普萘洛尔、硝苯地平及其联合用药的双盲比较。
Br Med J. 1980 Jul 19;281(6234):184-7. doi: 10.1136/bmj.281.6234.184.
8
Actions of isosorbide dinitrate on smooth muscle cells of rabbit vascular tissues.硝酸异山梨酯对兔血管组织平滑肌细胞的作用。
Br J Pharmacol. 1983 Jul;79(3):737-50. doi: 10.1111/j.1476-5381.1983.tb10012.x.
9
Calcium antagonists. Clinical use in the treatment of angina.钙拮抗剂。在心绞痛治疗中的临床应用。
Drugs. 1983 Feb;25(2):178-95. doi: 10.2165/00003495-198325020-00005.
10
Calcium antagonists. Clinical use in the treatment of systemic hypertension.钙拮抗剂。在系统性高血压治疗中的临床应用。
Drugs. 1983 Feb;25(2):154-77. doi: 10.2165/00003495-198325020-00004.

本文引用的文献

1
The effort test in angina pectoris.心绞痛的负荷试验。
Br Heart J. 1950 Oct;12(4):363-71. doi: 10.1136/hrt.12.4.363.
2
EFFECT OF PROPRANOLOL (INDERAL) IN ANGINA PECTORIS: PRELIMINARY REPORT.心得安(Inderal)治疗心绞痛的效果:初步报告。
Br Med J. 1964 Sep 19;2(5411):720-3. doi: 10.1136/bmj.2.5411.720.
3
RECORDING THE ELECTROCARDIOGRAM DURING THE PERFORMANCE OF THE MASTER TWO-STEP TEST. I.在进行二级梯运动试验时记录心电图。一、
Circulation. 1964 Feb;29:204-11. doi: 10.1161/01.cir.29.2.204.
4
EFFECT OF PRONETHALOL IN ANGINA PECTORIS.心得安对心绞痛的作用。
Br Med J. 1963 Nov 16;2(5367):1226-9. doi: 10.1136/bmj.2.5367.1226.
5
Radioelectrocardiographic changes during strenuous exercise in normal subjects.正常受试者剧烈运动时的放射心电图变化。
Circulation. 1962 Apr;25:686-94. doi: 10.1161/01.cir.25.4.686.
6
Radioelectrocardiography: a new technique for cardiovascular studies.放射心电图学:一种用于心血管研究的新技术。
Ann N Y Acad Sci. 1957 Aug 9;65(6):913-23. doi: 10.1111/j.1749-6632.1957.tb36693.x.
7
Cardiovascular actions of iproveratril.维拉帕米的心血管作用。
J Pharmacol Exp Ther. 1967 Dec;158(3):504-9.
8
Confirmatory physical findings in angina pectoris.心绞痛的确证性体格检查结果。
JAMA. 1967 Jun 19;200(12):1031-5.
9
The electrocardiogram during exercise. Its value in the diagnosis of angina pectoris.运动时的心电图。其在心绞痛诊断中的价值。
Circulation. 1965 Sep;32(3):477-87. doi: 10.1161/01.cir.32.3.477.
10
Telemetered heart rate response to selected competitive swimming events.遥测心率对选定竞技游泳项目的反应。
J Appl Physiol. 1969 Jun;26(6):764-70. doi: 10.1152/jappl.1969.26.6.764.